Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.52 |
| ▸ | DRD4 | P21917 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | ATM | Q13315 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1044851 | 0.93 | MAPT (0.53) | DRD2DRD4DRD3MAPTL3MBTL1 | |
| SCHEMBL1047361 | 0.91 | MAPT (0.51) | DRD2DRD4DRD3MAPTL3MBTL1 | |
| SCHEMBL6748734 | 0.91 | MAPT (0.51) | DRD2DRD4DRD3MAPTL3MBTL1 | |
| SCHEMBL72510 | 0.88 | CA12 (0.52) | DRD2DRD4DRD3MAPTL3MBTL1 | |
| SCHEMBL8434882 | 0.85 | CA12 (0.61) | DRD2DRD4DRD3MAPTL3MBTL1 | |
| SCHEMBL9808262 | 0.85 | MAPT (0.62) | DRD2DRD4DRD3MAPTL3MBTL1 | |
| SCHEMBL8778513 | 0.84 | LTA4H (0.57) | MAPTCA12CA1CA2CA7 | |
| SCHEMBL14984020 | 0.83 | MAPT (0.60) | DRD2DRD4DRD3MAPTL3MBTL1 | |
| SCHEMBL30514009 | 0.83 | MAPT (0.60) | DRD2DRD4DRD3MAPTL3MBTL1 | |
| SCHEMBL1343630 | 0.83 | CA12 (0.65) | DRD2DRD4DRD3MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117384079-B | Chiral N-alkyl indole compound and preparation method and application thereof | 云南大学 | 2024-05-24 | — | — | CN | claimed |
| CN-117384079-A | Chiral N-alkyl indole compound and preparation method and application thereof | 云南大学 | 2024-01-12 | — | — | CN | claimed |
| CN-115536704-A | Nitrogen bismuth octa-cycloalkyl bismuth compounds and synthesis method thereof | 湖南大学 | 2022-12-30 | — | — | CN | claimed |
| CN-110981768-A | Simple synthesis method of aryl difluoroalkyl sulfoxide compound | 山东理工大学 | 2020-04-10 | — | — | CN | claimed |
| CN-117384079-B | Chiral N-alkyl indole compound and preparation method and application thereof | 云南大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-117384079-A | Chiral N-alkyl indole compound and preparation method and application thereof | 云南大学 | 2024-01-12 | — | — | CN | disclosed |
| CN-115850666-A | Trithiophene alkyl sulfonic acid polymer, and preparation method and application thereof | 中国科学院化学研究所 | 2023-03-28 | — | — | CN | disclosed |
| US-20150224099-A1 | ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 2015-08-13 | — | — | US | disclosed |
| CN-102532162-B | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMA CO LTD | 2015-05-27 | — | — | CN | disclosed |
| US-8987304-B2 | Antituberculous composition comprising oxazole compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| US-8772268-B2 | Bisphosphonamidate prodrugs and uses thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-07-08 | — | — | US | disclosed |
| US-20130090311-A1 | BISPHOSPHONAMIDATE PRODRUGS AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY (US) | 2013-04-11 | — | — | US | disclosed |
| US-4918045-A | SUPPORTS, MICROCAPSULES CONTAINING COLORLESS ELECTRON-DONATING COLOR FORMER AND SOLVENT, AND ELECTRON-ACCEPTING DEVELOPER | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-17 | — | — | US | disclosed |
| US-4876233-A | NICKEL COMPOUNDS; COLORFASTNESS | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-24 | — | — | US | disclosed |
| US-4870048-A | COLORFAST IMAGE, LIGHT RESISTANCE | FUJI PHOTO FILM CO., LTD. (JP) | 1989-09-26 | — | — | US | disclosed |
| EP-0286041-A1 | Imidazothiadiazine derivatives, a process for preparing the same and their use as medicaments | HOECHST JAPAN LIMITED (JP) | 1988-10-12 | — | — | EP | disclosed |
| EP-0193813-A1 | Pyridine derivatives and fungicides containing them | BASF Aktiengesellschaft (DE) | 1986-09-10 | — | — | EP | disclosed |
| US-4590291-A | Thrombin inhibitory new dihydroxybenzene ether derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 1986-05-20 | — | — | US | disclosed |
| EP-0068250-A1 | Dioxybenzene ether derivatives, pharmaceutical compositions containing them, process for the preparation thereof and their use | BAYER AG (DE) | 1983-01-05 | — | — | EP | disclosed |
| US-4147869-A | ADRENERGIC BLOCKING AGENTS FOR TREATMENT OF ANGINA PECTORIS, ARRHYTHMIA AND HYPERTENSION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1979-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150224099-A1 | ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS | OXA1L, ARG1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | DRD2 2614/4885DRD4 888/4885DRD3 1127/4885 |
| US-20130090311-A1 | BISPHOSPHONAMIDATE PRODRUGS AND USES THEREOF | BPGM, PHPT1, PFKFB2 | DRD2 4055/4885DRD4 4403/4885DRD3 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.